Effect of Tribulus terrestris extract on blood glucose and lipids profile

Effect of Tribulus terrestris hydroalcoholic extract on blood glucose and lipids profile in 40 to 60 years old women with Diabetes Type II

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015062922971N1

Enrollment

100

Registered

2015-12-02

Start date

2014-12-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: intervention group: Tribulus Terrestris, capsules 500 mg twice daily for three months. Intervention 2: control group: Cellulose, 500 mg, twice daily for three months.

Treatment - Drugs

Placebo

intervention group: Tribulus Terrestris, capsules 500 mg twice daily for three months.

control group: Cellulose, 500 mg, twice daily for three months

Eligibility

Sex/Gender

Female

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: Willingness to cooperate and participate in the study; give written informed consent by the patient; not to use herbal remedies at least for a month before the study; ??not to be treated with hormonal compounds; to be controlled with oral hypoglycemic drugs; not to have any other chronic disease such as renal, hepatic or cardiovascular diseases, not to use vasodilators; negative family history of breast cancer; no diagnosed complication of diabetes or uncontrolled hypertension. Exclusion criteria: insulin therapy; non-compliance to the study protocol; Any sensitivity to TT or unusual drug side effects.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HbA1c. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;FBS. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;TG. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;Cholesterol. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;HDL. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;LDL. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;2hpp. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.	—

Measure

Time frame

HbA1c. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;FBS. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;TG. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;Cholesterol. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;HDL. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;LDL. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.;2hpp. Timepoint: Before the intervention, three months after intervention. Method of measurement: According mg/dl using lab kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Babadaei Samani

Shiraz Medical Science University

samani_nasrin@yahoo.com; babadaei@sums.ac.ir00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026